Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of Dabrafenib and Drug Combination for Patients with Metastatic Non-Clear Cell Kidney Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors
Not recruiting
Investigated Drugs:
+2
Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
+3
Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
Not recruiting
Investigated Drugs:
Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
+7